{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:32:11Z","timestamp":1793302331906,"version":"4.5.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["RTF23jan-0008"],"award-info":[{"award-number":["RTF23jan-0008"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00520-026-11283-9","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:02:54Z","timestamp":1790686974000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Time toxicity in cancer care: a systematic review of definitions and measurement methods"],"prefix":"10.1007","volume":"34","author":[{"given":"Ian Jun Yan","family":"Wee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheo Hao","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soh Si","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest Eu","family":"WenCong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tan Si","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain Tan Bee","family":"Huat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace Meijuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,29]]},"reference":[{"issue":"12","key":"11283_CR1","doi-asserted-by":"publisher","first-page":"e2547924","DOI":"10.1001\/jamanetworkopen.2025.47924","volume":"8","author":"A Gupta","year":"2025","unstructured":"Gupta A, Jazowski SA, Vaidya AU, Dusetzina SB, Ganguli I (2025) Health Care Contact Days in Older Adults With Metastatic Cancer. JAMA Netw Open 8(12):e2547924. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.47924","journal-title":"JAMA Netw Open"},{"issue":"4","key":"11283_CR2","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1093\/jnci\/djae252","volume":"117","author":"HM Parsons","year":"2025","unstructured":"Parsons HM, Gupta A, Jewett P, Vogel RI (2025) The intersecting time, administrative, and financial burdens of a cancer diagnosis. J Natl Cancer Inst 117(4):595\u2013600. https:\/\/doi.org\/10.1093\/jnci\/djae252","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"11283_CR3","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/S1470-2045(19)30456-5","volume":"20","author":"M Arnold","year":"1995","unstructured":"Arnold M, Rutherford MJ, Bardot A, Ferlay J, Andersson TML, Myklebust T\u00c5 et al (1995) Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study. Lancet Oncol 20(11):1493\u20131505. https:\/\/doi.org\/10.1016\/S1470-2045(19)30456-5","journal-title":"Lancet Oncol"},{"issue":"10","key":"11283_CR4","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/S1470-2045(11)70218-2","volume":"12","author":"MD Rawlins","year":"2011","unstructured":"Rawlins MD, Chalkidou K (2011) The opportunity cost of cancer care: a statement from NICE. Lancet Oncol 12(10):931\u2013932. https:\/\/doi.org\/10.1016\/S1470-2045(11)70218-2","journal-title":"Lancet Oncol"},{"issue":"15","key":"11283_CR5","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1200\/JCO.21.02810","volume":"40","author":"A Gupta","year":"2022","unstructured":"Gupta A, Eisenhauer EA, Booth CM (2022) The time toxicity of cancer treatment. J Clin Oncol 40(15):1611\u20131615. https:\/\/doi.org\/10.1200\/JCO.21.02810","journal-title":"J Clin Oncol"},{"key":"11283_CR6","doi-asserted-by":"publisher","unstructured":"Gupta A, O\u2019Callaghan C, Zhu L, Jonker D, Wong R, Colwell B et al (2022) Evaluating the time toxicity of cancer treatment in the CCTG CO.17 randomized clinical trial (RCT). J Clin Oncol 40(28) 248. Located at: CN-02493571. https:\/\/doi.org\/10.1200\/JCO.2022.40.28_suppl.248","DOI":"10.1200\/JCO.2022.40.28_suppl.248"},{"issue":"5","key":"11283_CR7","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.trecan.2023.01.006","volume":"9","author":"WV Johnson","year":"2023","unstructured":"Johnson WV, Blaes AH, Booth CM, Ganguli I, Gupta A (2023) The unequal burden of time toxicity. Trends Cancer 9(5):373\u2013375. https:\/\/doi.org\/10.1016\/j.trecan.2023.01.006","journal-title":"Trends Cancer"},{"issue":"11","key":"11283_CR8","doi-asserted-by":"publisher","first-page":"e2447649","DOI":"10.1001\/jamanetworkopen.2024.47649","volume":"7","author":"A Gupta","year":"2024","unstructured":"Gupta A, Johnson WV, Henderson NL, Ogunleye OO, Sekar P, George M et al (2024) Patient, caregiver, and clinician perspectives on the time burdens of cancer care. JAMA Netw Open 7(11):e2447649. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.47649","journal-title":"JAMA Netw Open"},{"issue":"11","key":"11283_CR9","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1093\/oncolo\/oyae187","volume":"29","author":"A Gupta","year":"2024","unstructured":"Gupta A, Brundage MD, Galica J, Karim S, Koven R, Ng TL et al (2024) Patients\u2019 considerations of time toxicity when assessing cancer treatments with marginal benefit. Oncologist 29(11):978\u2013985. https:\/\/doi.org\/10.1093\/oncolo\/oyae187","journal-title":"Oncologist"},{"issue":"16","key":"11283_CR10","doi-asserted-by":"publisher","first-page":"e13660","DOI":"10.1200\/jco.2023.41.16_suppl.e13660","volume":"41","author":"N Agrawal","year":"2023","unstructured":"Agrawal N, Thawani R, Chen ES (2023) Measuring time toxicity of systemic therapies for advanced esophageal and gastric cancers. J Clin Oncol 41(16):e13660. https:\/\/doi.org\/10.1200\/jco.2023.41.16_suppl.e13660","journal-title":"J Clin Oncol"},{"issue":"23","key":"11283_CR11","doi-asserted-by":"publisher","first-page":"5677","DOI":"10.3390\/cancers15235677","volume":"15","author":"NY Agrawal","year":"2023","unstructured":"Agrawal NY, Thawani R, Edmondson CP, Chen EY (2023) Estimating the time toxicity of contemporary systemic treatment regimens for advanced esophageal and gastric cancers. Cancers (Basel) 15(23):5677. https:\/\/doi.org\/10.3390\/cancers15235677","journal-title":"Cancers (Basel)"},{"issue":"22","key":"11283_CR12","doi-asserted-by":"publisher","first-page":"4249","DOI":"10.1002\/cncr.33817","volume":"127","author":"MB Lam","year":"2021","unstructured":"Lam MB, Riley KE, Zheng J, Orav EJ, Jha AK, Burke LG (2021) Healthy days at home: A population-based quality measure for cancer patients at the end of life. Cancer 127(22):4249\u20134257. https:\/\/doi.org\/10.1002\/cncr.33817","journal-title":"Cancer"},{"issue":"4","key":"11283_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-025-09335-7","volume":"33","author":"H Araie","year":"2025","unstructured":"Araie H, Seki T, Okada A, Yamauchi T, Nangaku M, Kadowaki T et al (2025) Temporal trends in time toxicity of R-CHOP: a nationwide hospital-based database analysis in Japan. Support Care Cancer 33(4):293. https:\/\/doi.org\/10.1007\/s00520-025-09335-7","journal-title":"Support Care Cancer"},{"issue":"11","key":"11283_CR14","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1001\/jamadermatol.2023.3179","volume":"159","author":"SB Bateni","year":"2023","unstructured":"Bateni SB, Nguyen P, Eskander A, Seung SJ, Mittmann N, Jalink M et al (2023) Changes in health care costs, survival, and time toxicity in the era of immunotherapy and targeted systemic therapy for melanoma. JAMA Dermatol 159(11):1195\u20131204. https:\/\/doi.org\/10.1001\/jamadermatol.2023.3179","journal-title":"JAMA Dermatol"},{"key":"11283_CR15","doi-asserted-by":"publisher","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews [Internet]. 2021 Mar 29. https:\/\/doi.org\/10.1136\/bmj.n71","DOI":"10.1136\/bmj.n71"},{"key":"11283_CR16","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jss.2019.12.035","volume":"251","author":"A Manjunathan","year":"2020","unstructured":"Manjunathan A, Gupta S, Kein C, Yang S, Mazurek A, Reddy RM (2020) A streamlined preoperative surgical oncology clinic workflow reduces patient burden. J Surg Res 251:146\u2013151. https:\/\/doi.org\/10.1016\/j.jss.2019.12.035","journal-title":"J Surg Res"},{"key":"11283_CR17","doi-asserted-by":"publisher","unstructured":"Bange E, Coughlin K, Li W, Brown T, Ragusano D, Balar E et al (2025) A Text Message Intervention to Minimize the Time Burden of Cancer Care. NEJM catalyst innovations in care delivery 6(3) 1\u20101. Located at: CN-02872706. https:\/\/doi.org\/10.1056\/CAT.24.0201","DOI":"10.1056\/CAT.24.0201"},{"key":"11283_CR18","doi-asserted-by":"publisher","unstructured":"Nindra U, Tang J, Hong JH, Descallar J, Hong M, Killen A et al (2025) Assessing patient-reported financial, social, and time toxicity in early-phase cancer clinical trials in australia through a prospective multicenter nonrandomized cohort study. JCO Oncol Pract OP2500412. https:\/\/doi.org\/10.1200\/OP-25-00412","DOI":"10.1200\/OP-25-00412"},{"key":"11283_CR19","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.jss.2022.11.009","volume":"283","author":"Z Duncan","year":"2023","unstructured":"Duncan Z, Garcia N, Correya T, Amu-Nnadi C, Broman K (2023) Burden of care for patients with in-transit melanoma. J Surg Res 283:550\u2013558. https:\/\/doi.org\/10.1016\/j.jss.2022.11.009","journal-title":"J Surg Res"},{"issue":"2","key":"11283_CR20","doi-asserted-by":"publisher","first-page":"e152","DOI":"10.1016\/j.clml.2020.09.010","volume":"21","author":"HS Mian","year":"2021","unstructured":"Mian HS, Fiala MA, Wildes TM (2021) Burden of treatment among older adults with newly diagnosed multiple myeloma. Clin Lymphoma Myeloma Leuk 21(2):e152\u2013e159. https:\/\/doi.org\/10.1016\/j.clml.2020.09.010","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"12","key":"11283_CR21","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.3390\/medicina59122121","volume":"59","author":"L Cavanna","year":"2023","unstructured":"Cavanna L, Citterio C, Mordenti P, Proietto M, Bosi C, Vecchia S (2023) Cancer treatment closer to the patient reduces travel burden, time toxicity, and improves patient satisfaction, results of 546 consecutive patients in a Northern Italian district. Medicina (Kaunas) 59(12):2121. https:\/\/doi.org\/10.3390\/medicina59122121","journal-title":"Medicina (Kaunas)"},{"issue":"3","key":"11283_CR22","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10549-024-07379-7","volume":"207","author":"SY Atre","year":"2024","unstructured":"Atre SY, Soulos PR, Kuderer NM, Gross CP, Baum LVM, Dinan MA et al (2024) Characterization of time toxicity in older patients with metastatic breast cancer. Breast Cancer Res Treat 207(3):541\u2013550. https:\/\/doi.org\/10.1007\/s10549-024-07379-7","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"11283_CR23","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s00520-015-2803-9","volume":"24","author":"OA Gladkov","year":"2016","unstructured":"Gladkov OA, Buchner A, Bias P, M\u00fcller U, Els\u00e4sser R (2016) Chemotherapy-associated treatment burden in breast cancer patients receiving lipegfilgrastim or pegfilgrastim: secondary efficacy data from a phase III study. Support Care Cancer 24(1):395\u2013400. https:\/\/doi.org\/10.1007\/s00520-015-2803-9","journal-title":"Support Care Cancer"},{"key":"11283_CR24","doi-asserted-by":"publisher","first-page":"100625","DOI":"10.1016\/j.jcpo.2025.100625","volume":"45","author":"S Kagalwalla","year":"2025","unstructured":"Kagalwalla S, Tsai AK, Tregear M, Maranda A, Idossa D, Blaes AH et al (2025) Comparing the time spent in clinic by patients receiving, subcutaneous and intravenous formulations of cancer drugs: A pilot study. J Cancer Policy 45:100625. https:\/\/doi.org\/10.1016\/j.jcpo.2025.100625","journal-title":"J Cancer Policy"},{"issue":"5","key":"11283_CR25","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1093\/oncolo\/oyae016","volume":"29","author":"S Kagalwalla","year":"2024","unstructured":"Kagalwalla S, Tsai AK, George M, Waldock A, Davis S, Jewett P et al (2024) Consuming patients\u2019 days: time spent on ambulatory appointments by people with cancer. Oncologist 29(5):400\u2013406. https:\/\/doi.org\/10.1093\/oncolo\/oyae016","journal-title":"Oncologist"},{"key":"11283_CR26","doi-asserted-by":"publisher","unstructured":"Gupta A, Hay AE, Crump M, Djurfeldt MS, Zhu L, Cheung MC et al (2023) Contact days associated with cancer treatments in the CCTG LY.12 Trial. Oncologist. 28(9) 799\u2013803. https:\/\/doi.org\/10.1093\/oncolo\/oyad128","DOI":"10.1093\/oncolo\/oyad128"},{"issue":"3","key":"11283_CR27","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezac148","volume":"62","author":"L Huang","year":"2022","unstructured":"Huang L, Frandsen MN, Kehlet H, Petersen RH (2022) Days alive and out of hospital after enhanced recovery video-assisted thoracoscopic surgery lobectomy. Eur J Cardiothorac Surg 62(3):ezac148. https:\/\/doi.org\/10.1093\/ejcts\/ezac148","journal-title":"Eur J Cardiothorac Surg"},{"issue":"10","key":"11283_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2023.107039","volume":"49","author":"AW Ekmann-Gade","year":"2023","unstructured":"Ekmann-Gade AW, H\u00f8gdall C, Seib\u00e6k L, Noer MC, Rasmussen A, Schnack TH (2023) Days alive and out of hospital after surgical treatment of epithelial ovarian cancer: a Danish nationwide cohort study. Eur J Surg Oncol 49(10):107039. https:\/\/doi.org\/10.1016\/j.ejso.2023.107039","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"11283_CR29","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1080\/00016489.2020.1836395","volume":"141","author":"SI Scott","year":"2021","unstructured":"Scott SI, Madsen AK\u00d8, Rubek N, Kehlet H, von Buchwald C (2021) Days alive and out of hospital after treatment for oropharyngeal squamous cell carcinoma with primary transoral robotic surgery or radiotherapy - a prospective cohort study. Acta Otolaryngol 141(2):193\u2013196. https:\/\/doi.org\/10.1080\/00016489.2020.1836395","journal-title":"Acta Otolaryngol"},{"issue":"1","key":"11283_CR30","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12957-026-04230-9","volume":"24","author":"W Liu","year":"2026","unstructured":"Liu W, Zhang Y, Lei C, Gao X, Zhao Y, Zhang K et al (2026) Days alive and out of hospital after video-assisted thoracoscopic lobectomy or segmentectomy for lung cancer: a prospective Chinese cohort study. World J Surg Oncol 24(1):119. https:\/\/doi.org\/10.1186\/s12957-026-04230-9","journal-title":"World J Surg Oncol"},{"issue":"6","key":"11283_CR31","doi-asserted-by":"publisher","DOI":"10.1093\/bjsopen\/zrad144","volume":"7","author":"L Huang","year":"2023","unstructured":"Huang L, Frandsen MN, Kehlet H, Petersen RH (2023) Days alive and out of hospital after video-assisted thoracoscopic surgery wedge resection in the era of enhanced recovery. BJS Open 7(6):zrad144. https:\/\/doi.org\/10.1093\/bjsopen\/zrad144","journal-title":"BJS Open"},{"issue":"1","key":"11283_CR32","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12876-025-04450-5","volume":"26","author":"KB Br\u00e4uner","year":"2025","unstructured":"Br\u00e4uner KB, Mashkoor M, Vogelsang RP, Bojesen RD, Rosen AW, G\u00f6genur I (2025) Days alive and out of hospital at 90 days as a composite outcome measure in patients undergoing elective surgery for colorectal cancer- a nationwide, observational study. BMC Gastroenterol 26(1):47. https:\/\/doi.org\/10.1186\/s12876-025-04450-5","journal-title":"BMC Gastroenterol"},{"issue":"12","key":"11283_CR33","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1080\/0284186X.2022.2156810","volume":"61","author":"HN Awada","year":"2022","unstructured":"Awada HN, Larsen MH, Kj\u00e6r EKR, Jensen JS, Jakobsen KK, Scott S et al (2022) Days alive and out of hospital following primary surgery for oral cavity squamous cell carcinoma. Acta Oncol 61(12):1463\u20131472. https:\/\/doi.org\/10.1080\/0284186X.2022.2156810","journal-title":"Acta Oncol"},{"issue":"12","key":"11283_CR34","doi-asserted-by":"publisher","first-page":"3866","DOI":"10.1002\/hed.26880","volume":"43","author":"MHH Larsen","year":"2021","unstructured":"Larsen MHH, Scott SI, Channir HI, Madsen AK\u00d8, Charabi BW, Rubek N et al (2021) Days alive and out of hospital following transoral robotic surgery: cohort study of 262 patients with head and neck cancer. Head Neck 43(12):3866\u20133874. https:\/\/doi.org\/10.1002\/hed.26880","journal-title":"Head Neck"},{"issue":"4","key":"11283_CR35","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1245\/s10434-024-16709-4","volume":"32","author":"OP Chatzipanagiotou","year":"2025","unstructured":"Chatzipanagiotou OP, Khalil M, Woldesenbet S, Catalano G, Pawlik TM (2025) Days at home after cancer surgery: impact of area deprivation and association with long-term outcomes. Ann Surg Oncol 32(4):2393\u20132402. https:\/\/doi.org\/10.1245\/s10434-024-16709-4","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"11283_CR36","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s11060-025-05014-z","volume":"173","author":"H Shakil","year":"2025","unstructured":"Shakil H, Malhotra AK, Essa A, Karthikeyan V, Lozano CS, He Y et al (2025) Days at home after treatment of spinal metastases: measurement and validation of a novel patient centered outcome. J Neurooncol 173(3):739\u2013749. https:\/\/doi.org\/10.1007\/s11060-025-05014-z","journal-title":"J Neurooncol"},{"issue":"5","key":"11283_CR37","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyaf046","volume":"30","author":"D Sentana-Lledo","year":"2025","unstructured":"Sentana-Lledo D, Barnett A, Einstein DJ, Gupta A, Morgans AK (2025) Days spent with healthcare contact by patients with metastatic castrate resistant prostate cancer in the last year of life. Oncologist 30(5):oyaf046. https:\/\/doi.org\/10.1093\/oncolo\/oyaf046","journal-title":"Oncologist"},{"issue":"11","key":"11283_CR38","doi-asserted-by":"publisher","DOI":"10.1097\/GOX.0000000000003904","volume":"9","author":"CW Swanick","year":"2021","unstructured":"Swanick CW, Jiang J, Maldonado JA, Lei X, Shih YCT, Caudle AS et al (2021) Differences in time burden across local therapy strategies for early-stage breast cancer. Plast Reconstr Surg 9(11):e3904. https:\/\/doi.org\/10.1097\/GOX.0000000000003904","journal-title":"Plast Reconstr Surg"},{"issue":"11","key":"11283_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2025.101578","volume":"7","author":"RWH Hui","year":"2025","unstructured":"Hui RWH, Chung MSH, Li L, Mao X, Chiang CL, Wong CKH et al (2025) Disparate patterns of disease time burden in patients with HCC on immunotherapy or tyrosine kinase inhibitors. JHEP Rep 7(11):101578. https:\/\/doi.org\/10.1016\/j.jhepr.2025.101578","journal-title":"JHEP Rep"},{"issue":"7","key":"11283_CR40","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.clml.2024.02.013","volume":"24","author":"R Banerjee","year":"2024","unstructured":"Banerjee R, Cowan AJ, Ortega M, Missimer C, Carpenter PA, Oshima MU et al (2024) Financial toxicity, time toxicity, and quality of life in multiple myeloma. Clin Lymphoma Myeloma Leuk 24(7):446-454.e3. https:\/\/doi.org\/10.1016\/j.clml.2024.02.013","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"7","key":"11283_CR41","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1200\/OP.23.00590","volume":"20","author":"A Gupta","year":"2024","unstructured":"Gupta A, Chant ED, Mohile S, Vogel RI, Parsons HM, Blaes AH et al (2024) Health care contact days among older cancer survivors. JCO Oncol Pract 20(7):943\u2013952. https:\/\/doi.org\/10.1200\/OP.23.00590","journal-title":"JCO Oncol Pract"},{"issue":"4","key":"11283_CR42","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.5033","volume":"8","author":"A Gupta","year":"2025","unstructured":"Gupta A, Nguyen P, Wilson BE, Booth CM, Hanna TP (2025) Health care contact days and outcomes in clinical trials vs routine care among patients with non-small cell lung cancer. JAMA Netw Open 8(4):e255033. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.5033","journal-title":"JAMA Netw Open"},{"issue":"11","key":"11283_CR43","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1200\/OP.23.00232","volume":"19","author":"VR Patel","year":"2023","unstructured":"Patel VR, Ramesh V, Tsai AK, Sedhom R, Westanmo AD, Blaes AH et al (2023) Health care contact days experienced by decedents with advanced GI cancer. JCO Oncol Pract 19(11):1031\u20131038. https:\/\/doi.org\/10.1200\/OP.23.00232","journal-title":"JCO Oncol Pract"},{"issue":"3","key":"11283_CR44","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.0778","volume":"8","author":"A Gupta","year":"2025","unstructured":"Gupta A, Till C, Vaidya R, Hershman DL, Unger JM (2025) Health care contact days for older adults enrolled in cancer clinical trials. JAMA Netw Open 8(3):e250778. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.0778","journal-title":"JAMA Netw Open"},{"key":"11283_CR45","doi-asserted-by":"publisher","first-page":"100121","DOI":"10.1016\/j.esmorw.2025.100121","volume":"8","author":"JL Low","year":"2025","unstructured":"Low JL, Wong RSJ, Chan ZY, Lee SC (2025) Health care policies, drug costs, and time toxicities in biologics for HER2-positive breast cancer: cost minimization analysis of direct and indirect costs. ESMO Real World Data Digit Oncol 8:100121. https:\/\/doi.org\/10.1016\/j.esmorw.2025.100121","journal-title":"ESMO Real World Data Digit Oncol"},{"issue":"5","key":"11283_CR46","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.3324\/haematol.2023.284133","volume":"109","author":"CE Jensen","year":"2024","unstructured":"Jensen CE, Deal AM, Wardell AC, Heiling HM, Beke KE, Richardson DR (2024) Home time among older adults with acute myeloid leukemia by therapy intensity. Haematologica 109(5):1588\u20131592. https:\/\/doi.org\/10.3324\/haematol.2023.284133","journal-title":"Haematologica"},{"issue":"8","key":"11283_CR47","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1001\/jamaoncol.2024.1823","volume":"10","author":"DR Richardson","year":"2024","unstructured":"Richardson DR, Zhou X, Reeder-Hayes K, Jensen CE, Islam J, Loh KP et al (2024) Home time among older adults with acute myeloid leukemia following chemotherapy. JAMA Oncol 10(8):1038\u20131046. https:\/\/doi.org\/10.1001\/jamaoncol.2024.1823","journal-title":"JAMA Oncol"},{"issue":"25","key":"11283_CR48","doi-asserted-by":"publisher","first-page":"00906","DOI":"10.1016\/j.bja.2025.11.059","volume":"S0007\u20130912","author":"CI Wells","year":"2026","unstructured":"Wells CI, Boyle L, Varghese C, Xu W, Baraza W, O\u2019Grady G et al (2026) Hospital variation in \u201cdays alive and out of hospital\u201d after colorectal cancer surgery: a national retrospective cohort study. Br J Anaesth S0007\u20130912(25):00906\u201300907. https:\/\/doi.org\/10.1016\/j.bja.2025.11.059","journal-title":"Br J Anaesth"},{"issue":"5","key":"11283_CR49","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1016\/j.juro.2014.06.004","volume":"192","author":"CR Ritch","year":"2014","unstructured":"Ritch CR, Cookson MS, Chang SS, Clark PE, Resnick MJ, Penson DF et al (2014) Impact of complications and hospital-free days on health related quality of life 1 year after radical cystectomy. J Urol 192(5):1360\u20131364. https:\/\/doi.org\/10.1016\/j.juro.2014.06.004","journal-title":"J Urol"},{"issue":"1","key":"11283_CR50","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s12905-025-03826-9","volume":"25","author":"AC Dona","year":"2025","unstructured":"Dona AC, Ambo A, Jewett P, Brown K, Parsons H, Gupta A et al (2025) Logistic and time burdens reported by gynecologic and breast cancer survivors. BMC Womens Health 25(1):273. https:\/\/doi.org\/10.1186\/s12905-025-03826-9","journal-title":"BMC Womens Health"},{"issue":"11","key":"11283_CR51","doi-asserted-by":"publisher","first-page":"e203754","DOI":"10.1001\/jamasurg.2020.3754","volume":"155","author":"TR Chesney","year":"2020","unstructured":"Chesney TR, Haas B, Coburn NG, Mahar AL, Zuk V, Zhao H et al (2020) Patient-centered time-at-home outcomes in older adults after surgical cancer treatment. JAMA Surg 155(11):e203754. https:\/\/doi.org\/10.1001\/jamasurg.2020.3754","journal-title":"JAMA Surg"},{"key":"11283_CR52","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ygyno.2026.02.007","volume":"206","author":"KY Lee","year":"2026","unstructured":"Lee KY, Tseng TH, Chang WC, Tai YJ, Wu CJ, Chiang YC et al (2026) Survival outcomes and time toxicity of Sandwich versus Sequential chemoradiation in Stage III endometrial cancer: A real-world study stratified by molecular classification. Gynecol Oncol 206:117\u2013124. https:\/\/doi.org\/10.1016\/j.ygyno.2026.02.007","journal-title":"Gynecol Oncol"},{"key":"11283_CR53","doi-asserted-by":"publisher","DOI":"10.1200\/OP.2024.20.10_suppl.133","author":"A Gupta","year":"2024","unstructured":"Gupta A, Nguyen P, Wilson B, Booth C, Hanna T (2024) The time toxicity efficacy-effectiveness gap: a population-based study of stage III\/ IV non-small cell lung cancer (NSCLC) in Ontario, Canada. JCO Oncol Pract. https:\/\/doi.org\/10.1200\/OP.2024.20.10_suppl.133","journal-title":"JCO Oncol Pract"},{"key":"11283_CR54","doi-asserted-by":"publisher","first-page":"1650378","DOI":"10.3389\/fonc.2025.1650378","volume":"15","author":"D Sentana-Lledo","year":"2025","unstructured":"Sentana-Lledo D, Gupta A, Rossi C, Burbage S, Korsiak J, Diaz L et al (2025) Time and cost burden associated with docetaxel in patients with metastatic castration-sensitive prostate cancer initiating an androgen receptor pathway inhibitor-based regimen. Front Oncol 15:1650378. https:\/\/doi.org\/10.3389\/fonc.2025.1650378","journal-title":"Front Oncol"},{"issue":"1","key":"11283_CR55","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s40487-026-00419-w","volume":"14","author":"E Smith","year":"2026","unstructured":"Smith E, Camera A, Bird A (2026) Time and resource implications of subcutaneous daratumumab-based versus intravenous isatuximab-based treatment regimens for patients with newly diagnosed multiple myeloma who are transplant ineligible. Oncol Ther 14(1):409\u2013422. https:\/\/doi.org\/10.1007\/s40487-026-00419-w","journal-title":"Oncol Ther"},{"issue":"12","key":"11283_CR56","doi-asserted-by":"publisher","first-page":"e2549957","DOI":"10.1001\/jamanetworkopen.2025.49957","volume":"8","author":"RI Vogel","year":"2025","unstructured":"Vogel RI, Jewett P, Parsons H, Brown K, Pecoraro A, Starks I et al (2025) Time burden in patients with metastatic breast and ovarian cancer from clinic and home demands. JAMA Netw Open 8(12):e2549957. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.49957","journal-title":"JAMA Netw Open"},{"issue":"4","key":"11283_CR57","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.3324\/haematol.2022.280728","volume":"108","author":"CE Jensen","year":"2023","unstructured":"Jensen CE, Heiling HM, Beke KE, Deal AM, Bryant AL, Coombs LA et al (2023) Time spent at home among older adults with acute myeloid leukemia receiving azacitidine- or venetoclax-based regimens. Haematologica 108(4):1006\u20131014. https:\/\/doi.org\/10.3324\/haematol.2022.280728","journal-title":"Haematologica"},{"issue":"9","key":"11283_CR58","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-024-08844-1","volume":"32","author":"JC Baltussen","year":"2024","unstructured":"Baltussen JC, C\u00e1rdenas-Reyes P, Chavarri-Guerra Y, Ramirez-Fontes A, Morales-Alfaro A, Portielje JEA et al (2024) Time toxicity among older patients with cancer treated with palliative systemic therapy. Support Care Cancer 32(9):621. https:\/\/doi.org\/10.1007\/s00520-024-08844-1","journal-title":"Support Care Cancer"},{"issue":"6","key":"11283_CR59","doi-asserted-by":"publisher","first-page":"102046","DOI":"10.1016\/j.esmoop.2023.102046","volume":"8","author":"U Nindra","year":"2023","unstructured":"Nindra U, Shivasabesan G, Childs S, Yoon R, Haider S, Hong M et al (2023) Time toxicity associated with early phase clinical trial participation. ESMO Open 8(6):102046. https:\/\/doi.org\/10.1016\/j.esmoop.2023.102046","journal-title":"ESMO Open"},{"issue":"2","key":"11283_CR60","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1007\/s00520-026-10359-w","volume":"34","author":"RH Nguyen","year":"2026","unstructured":"Nguyen RH, Tang J, Nindra U, Roohullah A, Yoon R, Tognela A et al (2026) Time toxicity associated with treatment of metastatic or unresectable gastro-oesophageal cancers in the second-line setting. Support Care Cancer 34(2):144. https:\/\/doi.org\/10.1007\/s00520-026-10359-w","journal-title":"Support Care Cancer"},{"issue":"1","key":"11283_CR61","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1136\/spcare-2025-005738","volume":"16","author":"S Mailankody","year":"2025","unstructured":"Mailankody S, Kotian D, Udupa KS, Pai A, Shetty P, Guddattu V et al (2025) Time toxicity during palliative chemotherapy for advanced malignancies: a prospective study. BMJ Support Palliat Care 16(1):130\u2013139. https:\/\/doi.org\/10.1136\/spcare-2025-005738","journal-title":"BMJ Support Palliat Care"},{"issue":"9","key":"11283_CR62","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1200\/OP.23.00811","volume":"20","author":"SM Durbin","year":"2024","unstructured":"Durbin SM, Lundquist DM, Pelletier A, Jimenez R, Petrillo L, Kim J et al (2024) Time toxicity experienced by early-phase cancer clinical trial participants. JCO Oncol Pract 20(9):1252\u20131262. https:\/\/doi.org\/10.1200\/OP.23.00811","journal-title":"JCO Oncol Pract"},{"key":"11283_CR63","doi-asserted-by":"publisher","first-page":"100379","DOI":"10.1016\/j.tipsro.2026.100379","volume":"37","author":"A Visanji","year":"2026","unstructured":"Visanji A, Li W, Winter J, Chung P, Kong V (2026) Time toxicity in CBCT-guided radiation therapy: A retrospective analysis of unplanned imaging burden across disease sites. Tech Innov Patient Support Radiat Oncol 37:100379. https:\/\/doi.org\/10.1016\/j.tipsro.2026.100379","journal-title":"Tech Innov Patient Support Radiat Oncol"},{"issue":"1","key":"11283_CR64","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1055\/a-2717-7930","volume":"86","author":"H Sch\u00e4ffler","year":"2026","unstructured":"Sch\u00e4ffler H, Heublein S, Lichtblau J, Wisniewski L, Rack B, Janni W et al (2026) Time toxicity of endocrine-based oral CDK4\/6 inhibitor therapies. Geburtshilfe Frauenheilkd 86(1):65\u201374. https:\/\/doi.org\/10.1055\/a-2717-7930","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"1","key":"11283_CR65","doi-asserted-by":"publisher","first-page":"e240028","DOI":"10.1530\/EO-24-0028","volume":"4","author":"MD Bortz","year":"2024","unstructured":"Bortz MD, Rodriguez A, Romina Luca M, Waisberg F, Enrico D, Freile B et al (2024) Time toxicity of lutetium 177 in gastroenteropancreatic neuroendocrine tumours. Endocr Oncol 4(1):e240028. https:\/\/doi.org\/10.1530\/EO-24-0028","journal-title":"Endocr Oncol"},{"issue":"8","key":"11283_CR66","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1080\/1750743X.2025.2518913","volume":"17","author":"M Bradbury","year":"2025","unstructured":"Bradbury M, Gabara A, Pond GR, Meyers BM, Kartolo A (2025) Time toxicity of nivolumab in metastatic head and neck squamous cell carcinoma patients: a single-institution experience. Immunotherapy 17(8):577\u2013583. https:\/\/doi.org\/10.1080\/1750743X.2025.2518913","journal-title":"Immunotherapy"},{"issue":"9","key":"11283_CR67","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1200\/OP-24-00526","volume":"21","author":"AG Ording","year":"2025","unstructured":"Ording AG, Skj\u00f8th F, Poulsen L\u00d8, Szejniuk WM, Jakobsen E, Christensen TD et al (2025) Time toxicity of systemic anticancer therapy for metastatic lung cancer in routine clinical practice: a nationwide cohort study. JCO Oncol Pract 21(9):1316\u20131324. https:\/\/doi.org\/10.1200\/OP-24-00526","journal-title":"JCO Oncol Pract"},{"issue":"4","key":"11283_CR68","doi-asserted-by":"publisher","first-page":"e244278","DOI":"10.1001\/jamanetworkopen.2024.4278","volume":"7","author":"A Gupta","year":"2024","unstructured":"Gupta A, Nguyen P, Kain D, Robinson AG, Kulkarni AA, Johnson DH et al (2024) Trajectories of health care contact days for patients with stage IV non-small cell lung cancer. JAMA Netw Open 7(4):e244278. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.4278","journal-title":"JAMA Netw Open"},{"issue":"2","key":"11283_CR69","doi-asserted-by":"publisher","first-page":"e290","DOI":"10.1093\/oncolo\/oyad313","volume":"29","author":"WV Johnson","year":"2024","unstructured":"Johnson WV, Phung QH, Patel VR, Tsai AK, Arora N, Klein MA et al (2024) Trajectory of Healthcare Contact Days for Veterans With Advanced Gastrointestinal Malignancy. Oncologist 29(2):e290\u2013e293. https:\/\/doi.org\/10.1093\/oncolo\/oyad313","journal-title":"Oncologist"},{"key":"11283_CR70","doi-asserted-by":"publisher","unstructured":"Invisible But Essential: A Qualitative Study on the Experiences of Informal Caregivers in Home-based Palliative Care - Samir Husi\u0107, Bojan Mileti\u0107, Sandra Boskovic, Marica Jerlekovic, Adriano Friganovic, Vedrana Vejzovic, 2025 [Internet]. [cited 2026 Mar 24]. Available from: https:\/\/journals-sagepub-com.libproxy1.nus.edu.sg\/doi\/full\/https:\/\/doi.org\/10.1177\/00469580251392458","DOI":"10.1177\/00469580251392458"},{"issue":"2","key":"11283_CR71","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3322\/caac.21443","volume":"68","author":"PM Carrera","year":"2018","unstructured":"Carrera PM, Kantarjian HM, Blinder VS (2018) The financial burden and distress of patients with cancer: understanding and stepping-up action on the financial toxicity of cancer treatment. CA Cancer J Clin 68(2):153\u2013165. https:\/\/doi.org\/10.3322\/caac.21443","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"11283_CR72","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-024-08487-2","volume":"32","author":"PL Quinn","year":"2024","unstructured":"Quinn PL, Saiyed S, Hannon C, Sarna A, Waterman BL, Cloyd JM et al (2024) Reporting time toxicity in prospective cancer clinical trials: a scoping review. Support Care Cancer 32(5):275. https:\/\/doi.org\/10.1007\/s00520-024-08487-2","journal-title":"Support Care Cancer"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11283-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-11283-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11283-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:02:37Z","timestamp":1793300557000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-11283-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,29]]},"references-count":72,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["11283"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-11283-9","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,29]]},"assertion":[{"value":"30 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article was originally published under the subscription model but it is now published under an Open Access license. The original article has been updated accordingly.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was not required for this study as it is a systematic review of previously published literature and does not involve the collection or use of individual-level patient data.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1035"}}